RCT Interview with Anellotech CEOs

Dr Charles Sorensen, PhD, vice president/research & development and David Sudolsky, president/CEO and co-founder of Anellotech with model of proposed research/development building planned for Pfizer’s Pearl River campus.

You must be logged in to post a comment Login